These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 3813760)

  • 1. Rebound hypertension following abrupt cessation of clonidine and metoprolol. Treatment with labetalol.
    Mehta JL; Lopez LM
    Arch Intern Med; 1987 Feb; 147(2):389-90. PubMed ID: 3813760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol.
    Rosei EA; Brown JJ; Lever AF; Robertson AS; Robertson JI; Trust PM
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):809-15. PubMed ID: 990158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypertensive crisis after withdrawal of clonidine and nadolol. Case report and review of the literature].
    Fried M; Schwander J
    Schweiz Med Wochenschr; 1987 Jun; 117(23):874-8. PubMed ID: 3303314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Labetalol treatment enhances the attenuation of tobacco withdrawal symptoms by nicotine in abstinent smokers.
    Sofuoglu M; Babb D; Hatsukami DK
    Nicotine Tob Res; 2003 Dec; 5(6):947-53. PubMed ID: 14668079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension.
    Rosei EA; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI; Trust PM
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):83-8. PubMed ID: 14627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of labetalol in hypertensive patients during discontinuation of clonidine therapy.
    Rosenthal T; Rabinowitz B; Boichis H; Elazar E; Brauner A; Neufeld HN
    Eur J Clin Pharmacol; 1981; 20(4):237-40. PubMed ID: 6273179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regimen for the control of blood pressure and symptoms during clonidine withdrawal.
    Campbell BC; Reid JL
    Int J Clin Pharmacol Res; 1985; 5(4):215-22. PubMed ID: 4055164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of clonidine rebound syndrome with sublingual captopril.
    Hauger-Klevene JH
    N Engl J Med; 1986 Jan; 314(3):181-2. PubMed ID: 3510386
    [No Abstract]   [Full Text] [Related]  

  • 9. Withdrawal of antihypertensive therapy. Hypertensive crisis in renovascular hypertension.
    Strauss FG; Franklin SS; Lewin AJ; Maxwell MH
    JAMA; 1977 Oct; 238(16):1734-6. PubMed ID: 578267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of labetalol in the treatment of hypertensive crises].
    Semplicini A; Pessina AC; Rossi GP; Palatini P; Hlede M; Morandin F; Visonà A; Mazzucato A; Dal Palù C
    G Ital Cardiol; 1982; 12(5):355-8. PubMed ID: 7152187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous labetalol in the treatment of severe hypertension.
    Cumming AM; Brown JJ; Lever AF; Robertson JI
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):93S-96S. PubMed ID: 7093105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of hypertensive crises with a mono-substance with alpha- and beta-blocking properties (labetalol)].
    Holzer H; Pogglitsch H; Katschnig H; Korthals C
    Wien Med Wochenschr Suppl; 1981; 69():10-3. PubMed ID: 6952657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central alpha-adrenergic control of blood pressure. Effects of clonidine withdrawal.
    Augustine SJ; Tachikawa S; Lokhandwala MF; Buckley JP
    Chest; 1983 Feb; 83(2 Suppl):328-31. PubMed ID: 6295708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Withdrawal syndrome following cessation of antihypertensive drug therapy.
    Karachalios GN; Charalabopoulos A; Papalimneou V; Kiortsis D; Dimicco P; Kostoula OK; Charalabopoulos K
    Int J Clin Pract; 2005 May; 59(5):562-70. PubMed ID: 15857353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient].
    Sassard J; Zech PY; Pozet N; Cuisinaud G; Vincent M
    J Pharmacol; 1983; 14 Suppl 2():121-9. PubMed ID: 6355664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of severe essential hypertension with labetalol: effect on active and inactive renin.
    Hauger-Klevene JH
    Pharmatherapeutica; 1981; 3(1):46-54. PubMed ID: 7033992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Labetalol and the management of hypertension.
    Reid JL; Meredith PA; Elliott HL
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S60-8. PubMed ID: 6169961
    [No Abstract]   [Full Text] [Related]  

  • 18. Labetalol, beta blockers, and acute deterioration of chronic airway obstruction.
    Adam WR; Meagher EJ; Barter CE
    Clin Exp Hypertens A; 1982; 4(8):1419-28. PubMed ID: 6126285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of 2 beta-blockers on arterial hypertension during pregnancy. Results of a prospective study on 56 pregnant hypertensive women treated with atenolol and labetalol].
    Gérard J; Blazquez G; Lardoux H; Beauséjour B; Faurie C; Rousset D; Flouvat B
    J Gynecol Obstet Biol Reprod (Paris); 1983; 12(8):891-900. PubMed ID: 6672083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical, ergometric and polygraphic evaluation of the effects of metoprolol and labetalol administration in essential arterial hypertension. Comparative study].
    Schirripa V; Attisano N; Sarica G; Grenci G; Martelli G
    Minerva Med; 1982 Apr; 73(14):845-9. PubMed ID: 7070696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.